What does Geron Corp. do?

Jun 22 2025 06:14 PM IST
share
Share Via
Geron Corporation is a late-stage clinical biopharmaceutical company focused on developing imetelstat for hematologic myeloid malignancies, with a market cap of approximately $923.53 million. As of March 2025, it reported net sales of $40 million and a net loss of $20 million.
Overview:
Geron Corporation is a late-stage clinical biopharmaceutical company focused on the development and commercialization of imetelstat, a therapeutic for hematologic myeloid malignancies, operating in the Pharmaceuticals & Biotechnology industry with a micro-cap market capitalization.

Financial Snapshot:
Most recent Net Sales: 40 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -20 Million (Quarterly Results - Mar 2025)
Market cap: USD 923.53 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.57
Return on Equity: -51.19%
Price to Book: 3.44

Contact Details:
Address: 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY CA: 94404
Tel: 1 650 4737700
Fax: 1 302 6365454
Website: http://www.geron.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Geron Corp. Hits Day Low of $1.04 Amid Price Pressure
Nov 06 2025 04:11 PM IST
share
Share Via
Is Geron Corp. technically bullish or bearish?
Sep 20 2025 07:16 PM IST
share
Share Via
Is Geron Corp. overvalued or undervalued?
Sep 20 2025 05:51 PM IST
share
Share Via
Is Geron Corp. overvalued or undervalued?
Jun 25 2025 08:28 AM IST
share
Share Via
Is Geron Corp. technically bullish or bearish?
Jun 25 2025 08:25 AM IST
share
Share Via
Who are in the management team of Geron Corp.?
Jun 22 2025 10:12 PM IST
share
Share Via